Resolution for winding up (MVL)
VIMELA THERAPEUTICS LIMITED
Vimela Therapeutics Ltd has resolved to voluntarily wind up the company and appointed James Hopkirk as liquidator.
Notice details
- Company
- VIMELA THERAPEUTICS LIMITED
- Company number
- 13611487
- Registered office
- The Cambridge Partnership The Dorothy Hodgkin Building, Babraham Research Campus, Cambridge, CB22 3FH
- Principal trading address
- The Cambridge Partnership The Dorothy Hodgkin Building, Babraham Research Campus, Cambridge, Cambridgeshire, CB22 3FH
- Place of meeting
- The Cambridge Partnership The Dorothy Hodgkin Building, Babraham Research Campus, Cambridge, CB22 3FH
- Date of meeting
- 30 June 2026
- Time of meeting
- 16:45 pm
- Type of liquidation
- Voluntary winding up (MVL)
- Liquidator
- James Hopkirk (IP No. 21150) of Kreston Reeves LLP, 2nd Floor Maritime Place, Quayside, Chatham Maritime, Kent, ME4 4QZ
- Date of appointment
- 30 June 2026
- Contact
- Mansi Thawani, 01634 899800, [email protected]
Planning a solvent wind-down or restructure?
A members' voluntary liquidation is a solvent, orderly closure — often part of retirement, a group restructure, or moving on to the next venture. K2 has advised UK company directors since 1990 on restructuring and what comes next. If that's on your horizon, talk to us.
Related guidance
Free, practical guides from K2 on what this kind of notice means for directors.
More liquidation notices
Source: The London Gazette and Companies House. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright. This page is provided by K2 Partners for information only and is not legal or financial advice.